Metropolitan Life Insurance Company (MetLife)’s Advanced Micro Devices AMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-65,169
Closed -$11.8M 116
2024
Q1
$11.8M Sell
65,169
-596
-0.9% -$104K 0.51% 28
2023
Q4
$9.69M Sell
65,765
-1,082
-2% -$128K 0.46% 31
2023
Q3
$6.87M Sell
66,847
-3,331
-5% -$362K 0.36% 47
2023
Q2
$7.99M Sell
70,178
-1,939
-3% -$202K 0.39% 45
2023
Q1
$7.07M Sell
72,117
-19,095
-21% -$1.55M 0.36% 49
2022
Q4
$5.91M Sell
91,212
-1,483
-2% -$97.9K 0.26% 83
2022
Q3
$5.87M Sell
92,695
-1,500
-2% -$128K 0.28% 73
2022
Q2
$7.2M Sell
94,195
-3,261
-3% -$305K 0.32% 63
2022
Q1
$10.7M Sell
97,456
-94,585
-49% -$11.3M 0.38% 47
2021
Q4
$27.6M Sell
192,041
-5,090
-3% -$684K 0.38% 42
2021
Q3
$20.3M Sell
197,131
-6,751
-3% -$690K 0.29% 59
2021
Q2
$19.2M Sell
203,882
-1,032
-0.5% -$83.4K 0.27% 64
2021
Q1
$16.1M Sell
204,914
-10,864
-5% -$935K 0.24% 75
2020
Q4
$19.8M Sell
215,778
-3,085
-1% -$266K 0.3% 59
2020
Q3
$17.9M Sell
218,863
-8,603
-4% -$639K 0.3% 62
2020
Q2
$12M Buy
227,466
+9,841
+5% +$522K 0.21% 86
2020
Q1
$9.9M Buy
217,625
+4,035
+2% +$194K 0.2% 93
2019
Q4
$9.8M Buy
213,590
+4,597
+2% +$169K 0.16% 115
2019
Q3
$6.06M Buy
208,993
+29,976
+17% +$940K 0.1% 173
2019
Q2
$5.44M Buy
179,017
+9,503
+6% +$271K 0.09% 196
2019
Q1
$4.33M Sell
169,514
-6,321
-4% -$144K 0.08% 213
2018
Q4
$3.25M Buy
175,835
+2,309
+1% +$49.9K 0.07% 244
2018
Q3
$5.36M Buy
173,526
+232
+0.1% +$5.24K 0.09% 189
2018
Q2
$2.6M Buy
173,294
+6,642
+4% +$84.4K 0.04% 379
2018
Q1
$1.67M Buy
166,652
+1,206
+0.7% +$14.3K 0.02% 643
2017
Q4
$1.7M Sell
165,446
-252,227
-60% -$2.95M 0.02% 635
2017
Q3
$5.33M Buy
417,673
+8,275
+2% +$108K 0.03% 554
2017
Q2
$5.11M Sell
409,398
-459,058
-53% -$5.61M 0.04% 559
2017
Q1
$12.6M Sell
868,456
-338,548
-28% -$4.3M 0.09% 221
2016
Q4
$13.7M Buy
1,207,004
+75,334
+7% +$632K 0.1% 195
2016
Q3
$7.82M Buy
1,131,670
+76,351
+7% +$487K 0.06% 314
2016
Q2
$5.42M Buy
1,055,319
+50,344
+5% +$196K 0.04% 477
2016
Q1
$2.86M Buy
1,004,975
+18,577
+2% +$42.2K 0.02% 768
2015
Q4
$2.83M Buy
986,398
+9,882
+1% +$22.1K 0.02% 759
2015
Q3
$1.68M Sell
976,516
-17,320
-2% -$32.6K 0.01% 975
2015
Q2
$2.38M Buy
993,836
+414,316
+71% +$1M 0.02% 899
2015
Q1
$1.55M Buy
579,520
+20,533
+4% +$57.7K 0.01% 981
2014
Q4
$1.49M Buy
558,987
+10,699
+2% +$29.4K 0.01% 1092
2014
Q3
$1.87M Sell
548,288
-17,587
-3% -$71.2K 0.01% 977
2014
Q2
$2.37M Buy
565,875
+26,595
+5% +$108K 0.02% 921
2014
Q1
$2.16M Buy
539,280
+11,415
+2% +$43.6K 0.02% 945
2013
Q4
$2.04M Buy
527,865
+4,501
+0.9% +$16.1K 0.01% 970
2013
Q3
$1.99M Buy
523,364
+112,068
+27% +$427K 0.02% 930
2013
Q2
$1.68M Buy
+411,296
New +$1.42M 0.01% 974

Other funds holding AMD

Metropolitan Life Insurance Company (MetLife)'s AMD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Advanced Micro Devices (AMD) in Q2 2024, closing a stake of 65,169 shares — an estimated $11.8M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AMD in Q2 2013 and held it in 44 quarters. The position peaked at $27.6M in Q4 2021. 2,478 funds tracked by Wall St. Rank hold AMD as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Advanced Micro Devices position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 65,169 Advanced Micro Devices shares in Q2 2024, an estimated $11.8M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Advanced Micro Devices in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Advanced Micro Devices position peaked at $27.6M in Q4 2021.
  • 2,478 funds tracked by Wall St. Rank held Advanced Micro Devices as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.